Albuterol Sulfate; Ipratropium Bromide Patent Expiration

Albuterol Sulfate; Ipratropium Bromide was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Combivent on Oct 24, 1996. Other drugs containing Albuterol Sulfate; Ipratropium Bromide are Duoneb, Combivent Respimat. 11 different companies have introduced drugs containing Albuterol Sulfate; Ipratropium Bromide.


Albuterol Sulfate; Ipratropium Bromide Patents

Given below is the list of patents protecting Albuterol Sulfate; Ipratropium Bromide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Combivent US5603918 Aerosol composition of a salt of ipratropium and a salt of albuterol Jun 09, 2015

(Expired)

Boehringer Ingelheim
Combivent Respimat US5472143 Atomising nozzle and filter and spray generation device Sep 29, 2013

(Expired)

Boehringer Ingelheim
Combivent Respimat US5497944 Atomising devices and methods Mar 12, 2013

(Expired)

Boehringer Ingelheim
Combivent Respimat US5662271 Atomizing devices and methods Sep 02, 2014

(Expired)

Boehringer Ingelheim
Combivent Respimat US5911851 Atomizing nozzle and filter and spray generating device Sep 29, 2013

(Expired)

Boehringer Ingelheim
Combivent Respimat US5964416 Device for producing high pressure in a fluid in miniature Oct 04, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US6007676 Atomizing nozzle and filter and spray generating device Sep 29, 2013

(Expired)

Boehringer Ingelheim
Combivent Respimat US6149054 Mechanical counter for a metering apparatus Dec 19, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US6176442 Device for mounting a component exposed to a pressurized fluid Oct 04, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US6453795 Locking mechanism for a spring-actuated device Dec 05, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US6503362 Atomizing nozzle an filter and spray generating device Sep 29, 2013

(Expired)

Boehringer Ingelheim
Combivent Respimat US6726124 Device for producing high pressure in a fluid in miniature Oct 04, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US6846413 Microstructured filter Aug 28, 2018

(Expired)

Boehringer Ingelheim
Combivent Respimat US6977042 Microstructured filter Aug 28, 2018

(Expired)

Boehringer Ingelheim
Combivent Respimat US6988496 Cartridge for a liquid Feb 23, 2020

(Expired)

Boehringer Ingelheim
Combivent Respimat US7104470 Device for producing high pressure in a fluid in miniature Oct 04, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US7246615 Atomising nozzle and filter and spray generating device May 31, 2016

(Expired)

Boehringer Ingelheim
Combivent Respimat US7284474 Piston-pumping system having o-ring seal properties Aug 26, 2024 Boehringer Ingelheim
Combivent Respimat US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device Oct 10, 2026 Boehringer Ingelheim
Combivent Respimat US7802568 Cartridge for a liquid Feb 26, 2019

(Expired)

Boehringer Ingelheim
Combivent Respimat US7837235 Device for clamping a fluidic component Mar 13, 2028 Boehringer Ingelheim
Combivent Respimat US7896264 Microstructured high pressure nozzle with built-in filter function May 26, 2025 Boehringer Ingelheim
Combivent Respimat US7988001 Container provided with a pressure equalization opening Aug 04, 2021

(Expired)

Boehringer Ingelheim
Combivent Respimat US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism Oct 16, 2030 Boehringer Ingelheim
Combivent Respimat US9027967 Device for clamping a fluidic component Mar 31, 2027 Boehringer Ingelheim
Duoneb US6632842 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease Dec 28, 2021

(Expired)

Mylan Speciality Lp


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Albuterol Sulfate; Ipratropium Bromide Generics

Several generic applications have been filed for Albuterol Sulfate; Ipratropium Bromide. The first generic version for Albuterol Sulfate; Ipratropium Bromide was by Fosun Pharma Usa Inc and was approved on Dec 21, 2006. And the latest generic version is by Luoxin Aurovitas Pharma Chengdu Co Ltd and was approved on Jul 8, 2020.

Given below is the list of companies who have filed for Albuterol Sulfate; Ipratropium Bromide generic.


1. CIPLA

Cipla Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Prescription INHALATION AN Dec 31, 2007


2. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Discontinued INHALATION N/A Dec 31, 2007


3. APOTEX INC

Apotex Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Discontinued INHALATION N/A Dec 31, 2007


4. LUOXIN AUROVITAS

Luoxin Aurovitas Pharma Chengdu Co Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Luoxin Aurovitas.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Discontinued INHALATION N/A Jul 8, 2020


5. FOSUN PHARMA

Fosun Pharma Usa Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Fosun Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Discontinued INHALATION N/A Dec 21, 2006


6. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Prescription INHALATION AN Aug 7, 2017


7. NEPHRON

Nephron Pharmaceuticals Corp has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Nephron.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017%

(reference standard)

solution Prescription INHALATION AN Dec 31, 2007


8. RITEDOSE CORP

The Ritedose Corp has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Ritedose Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Prescription INHALATION AN Oct 1, 2012


9. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.083% BASE; 0.017% solution Discontinued INHALATION N/A Dec 31, 2007